Emerging evidence suggests that hyperglucagonemia is more strongly associated with obesity and NAFLD than with diabetes itself; elevated fasting glucagon levels have been observed even in individuals with obesity and normal glucose tolerance [28]. This evidence concerns the gene GCG and metabolic dysfunction-associated steatotic liver disease.